Assessing the effectiveness of using the Community Directed Intervention (CDI) approach to improve community ownership of Mass Drug Administration (MDA) for Neglected Tropical Diseases (NTDs) in Malawi
Not Applicable
- Conditions
- Schistosomiasis and soil-transmitted helminths
- Registration Number
- PACTR202102477794401
- Lead Sponsor
- TD Support Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- All
- Target Recruitment
- 48676
Inclusion Criteria
All children aged above 5 years as well as the at risk adults residing in the study communities. The study population includes minors (aged under 18 years) because they constitute the high risk for schistosomiasis and STH due to frequent water exposure, heavy infection intensity and morbidity
Exclusion Criteria
All children aged below 5 years, the clinically sick, pregnant women and the elderly
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does CDI-based MDA improve adherence to anthelmintic treatment for schistosomiasis and soil-transmitted helminths in Malawi?
What molecular mechanisms underlie resistance to praziquantel and albendazole in schistosome and helminth populations in Malawi?
Are there biomarkers of community engagement that correlate with MDA coverage rates in CDI programs targeting NTDs?
What adverse events are reported in CDI-led versus health-worker-administered MDA for schistosomiasis in sub-Saharan Africa?
How does CDI compare to community-directed distributors (CDDs) in sustaining NTD control through mass drug administration?